Molbio Diagnostics Ipo News

Molbio Diagnostics shares debuted at a 21.44% premium on both BSE and NSE, listing at ₹980 against an issue price of ₹807, despite a weak overall stock market.

Molbio Diagnostics' IPO shares are set to list on both the NSE and BSE tomorrow, following the finalization of allotment on August 13th.

Molbio Diagnostics is poised for a strong stock market debut on Monday, with its IPO oversubscribed 70 times and a grey market premium indicating a nearly 20% l

The allotment for Molbio Diagnostics IPO will be finalized today, August 13, with investors able to check their status via Kfin Technologies; the IPO was oversu

Molbio Diagnostics offered its shares in an IPO with a price band of Rs 768-807 per share, allowing investors to apply for a minimum of 18 shares to raise Rs 94

Molbio Diagnostics IPO allotment is expected on Thursday, following a 70.26 times subscription for the Rs 939.70-crore issue. With a 20% grey market premium, in

The Molbio Diagnostics IPO has been subscribed 17.37 times by Day 3, with a grey market premium (GMP) of ₹138 per share, indicating strong investor interest.

Molbio Diagnostics IPO has been subscribed 1.22 times by Day 2, with its grey market premium (GMP) currently at around ₹124 per share, indicating strong demand.

Molbio Diagnostics' IPO, aiming to raise ₹904-940 crore, was 14% booked on Day 1, with a grey market premium (GMP) hinting at a 69% listing pop, following ₹281.

Molbio Diagnostics Limited has announced its IPO price band between ₹768 and ₹807 per share. Subscriptions for the IPO will be open from August 10 to August 12,